Yusuke Sakai

1.6k citations
77 papers · 899 indexed · h-index 16
Topics
Veterinary Oncology Research (14 papers)SARS-CoV-2 and COVID-19 Research (9 papers)Virus-based gene therapy research (7 papers)

In The Last Decade

Yusuke Sakai

70 papers receiving 884 citations

Peers

Yusuke Sakai
Comparison fields: 5 of 127
  • Infectious Diseases 292
  • Molecular Biology 222
  • Immunology 166
  • Pulmonary and Respiratory Medicine 151
  • Oncology 135
Replace Julie A. Dragon with:
Julie A. Dragon United States
Rui Ye China
Kayo Suzuki Japan
Vishnu M. Dhople Germany
Kateřina Komrsková Czechia
Richard D. Head United States
Andreas Böck Germany
Jianqiang Shao United States
Daniel J. MacPhee Canada
Mona Aleksandersen Norway
Yusuke Sakai relative to Julie A. Dragon United States Julie A. Dragon's profile →
Citations per field
00.5×1.5×2.0×
Julie A. Dragon · 1×
Citations per year

Countries citing papers authored by Yusuke Sakai

Since Specialization
Citations

This map shows the geographic impact of Yusuke Sakai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuke Sakai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuke Sakai more than expected).

Fields of papers citing papers by Yusuke Sakai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusuke Sakai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuke Sakai. The network helps show where Yusuke Sakai may publish in the future.

Co-authorship network of co-authors of Yusuke Sakai

This figure shows the co-authorship network connecting the top 25 collaborators of Yusuke Sakai. A scholar is included among the top collaborators of Yusuke Sakai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusuke Sakai. Yusuke Sakai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 6
3 2
4 2
5 2
6 2
7 4
8 12
9 6
10 35
11 19
12 76
13 1
14 30
15 39
16 2
17 0
18 0
19 1
20 0

About Yusuke Sakai

Yusuke Sakai is a scholar working on Infectious Diseases, Surfaces, Coatings and Films and Immunology, having authored 77 papers that have together received 899 indexed citations. Recurring topics across this work include Veterinary Oncology Research (14 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Virus-based gene therapy research (7 papers). The work is most often cited by research in Infectious Diseases (292 citations), Immunology (166 citations) and Environmental Chemistry (53 citations). Yusuke Sakai has collaborated with scholars based in Japan, Indonesia and United States. Frequent co-authors include Yoshiharu Matsuura, Masashi Sakurai, Hiroko Omori, Wataru Kamitani, Yutaka Terada, Takuya Mizuno, Masaya Igase, Masayuki Saijo, Masahiro Kato and Motoi Machida. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026